With pharmaceutical and biotechnology R&D witnessing unprecedented growth, molecular spectroscopy methods such as nuclear magnetic resonance (NMR), Fourier transform infrared (FTIR), and Raman ...

Thermo Fisher’s acqusition of Solventum will strenghtnen its capabilities in bioprocessing. Image credit: JHVEPhoto / Shutterstock. Thermo Fisher Scientific is acquiring Solventum’s purification & ...

Update 9:45am: Companies confirm deal details. Thermo Fisher Scientific (NYSE:TMO) confirmed that it agreed to purchase Solventum's purification and fitration unit for $4.1 billion in cash.

On the heels of a move to reduce its viral vector manufacturing workforce, Thermo Fisher is beefing up its ... That deal complements the CDMO’s mass spectrometry offerings.

(Reuters) -Contract drug manufacturer Thermo Fisher Scientific said on Tuesday it will buy Solventum's purification and filtration business for about $4.1 billion, sending the latter's shares up ...

Thermo Fisher (TMO) announced that the company has entered into a definitive agreement with Solventum (SOLV) to acquire Solventum’s Purification & Filtration business for approximately $4.1B in ...

WALTHAM, Mass., February 25, 2025--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher"), the world leader in serving science, today announced that the company has entered ...

Thermo Fisher Scientific is growing its lab equipment empire with a deal to buy 3M’s former purification and filtration business for $4.1 billion. Waltham-based Thermo is buying the business ...

The business, which provides filters for the purification of food or beverages and drugs during development, brought in about $1 billion in revenue in 2024, Thermo said. Evercore analyst Vijay ...

Thermo Fisher Scientific agreed to pay about $4.1 billion in cash to acquire Solventum’s purification and filtration business. The technologies, used in the production of biologics and medical devices ...

Thermo Fisher said it is paying about $4.1 billion in cash for the business. The Journal reported in October that Solventum, the healthcare company spun off from 3M last year, had retained bankers ...